{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:21Z","timestamp":1791655401529,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vitreoretinal lymphoma (VRL) is a rare intraocular malignancy that poses a diagnostic challenge due to the non-specific clinical presentation that resembles uveitis. The use of spectral domain optical coherence tomography (SD-OCT) has emerged as a valuable imaging tool to characterize VRL. Therefore, we sought to determine the specific OCT features in VRL compared to the uveitides.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective chart review of patients who were seen at Mayo Clinic from January 1, 2010 through December 31, 2022.<\/jats:p>\n                <jats:p>The medical records and SD-OCT images at time of initial presentation were reviewed in patients with biopsy-proven VRL, intermediate uveitis, or biopsy-confirmed sarcoid posterior uveitis. Patients with VRL or similar uveitides including intermediate uveitis or sarcoid posterior uveitis were included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 95 eyes of 56 patients in the VRL group and 86 eyes of 45 patients in the uveitis group, of whom 15 (33.3%) were diagnosed with intermediate uveitis and 30 (66.7%) with sarcoid chorioretinitis. The SD-OCT features more commonly seen at initial presentation in VRL patients (vs. uveitis) included preretinal deposits (31.6% vs. 9.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.002), intraretinal infiltrates (34% vs. 3.5%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), inner retinal hyperreflective spots (15.8% vs. 0%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), outer retinal atrophy (22.1% vs. 2.3%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), subretinal focal deposits (21.1% vs. 4.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), retinal pigmented epithelium (RPE) changes (49.5% vs. 3.5%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and sub-RPE deposits (34.7% vs. 0%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Features more frequently seen in uveitis included epiretinal membrane (ERM) (82.6% vs. 44.2%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), central macular thickening (95.3% vs. 51.6%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), cystoid macular edema (36% vs. 11.7%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), subretinal fluid (16.3% vs 6.4%, <jats:italic>p<\/jats:italic>\u2009=\u20090.04), and subfoveal fluid (16.3% vs. 3.2%, <jats:italic>p<\/jats:italic>\u2009=\u20090.003). Multivariate regression analysis controlling for age and sex showed absence of ERM (OR 0.14 [0.04,0.41], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and absence of central macular thickening (OR 0.03 [0,0.15], <jats:italic>p<\/jats:italic>\u2009=\u20090.02) were associated with VRL as opposed to uveitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>OCT features most predictive of VRL (vs. uveitis) included absence of ERM and central macular thickening.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03513-7","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T08:01:59Z","timestamp":1718265719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis"],"prefix":"10.1186","volume":"24","author":[{"given":"Lulwa","family":"El Zein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Launia J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose S.","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Dalvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"4","key":"3513_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/107327489800500403","volume":"5","author":"DS Bardenstein","year":"1998","unstructured":"Bardenstein DS. Intraocular Lymphoma. Cancer Control. 1998;5(4):317\u201325.","journal-title":"Cancer Control"},{"issue":"9","key":"3513_CR2","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0161-6420(93)31469-7","volume":"100","author":"SM Whitcup","year":"1993","unstructured":"Whitcup SM, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100(9):1399\u2013406.","journal-title":"Ophthalmology"},{"issue":"1","key":"3513_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaophthalmol.2013.569","volume":"131","author":"SD Levasseur","year":"2013","unstructured":"Levasseur SD, Wittenberg LA, White VA. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA Ophthalmol. 2013;131(1):50\u20135.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"3513_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1442-9071.2008.01843.x","volume":"36","author":"SE Coupland","year":"2008","unstructured":"Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008;36(6):564\u201378.","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"3513_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00055735-200212000-00012","volume":"13","author":"CC Chan","year":"2002","unstructured":"Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002;13(6):411\u20138.","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"3513_CR6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.4103\/ijo.IJO_570_20","volume":"68","author":"SR Rathinam","year":"2020","unstructured":"Rathinam SR, et al. Immunological tests and their interpretation in uveitis. Indian J Ophthalmol. 2020;68(9):1737\u201348.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"3513_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/09273940903108544","volume":"17","author":"HN Sen","year":"2009","unstructured":"Sen HN, et al. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm. 2009;17(3):133\u201341.","journal-title":"Ocul Immunol Inflamm"},{"key":"3513_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2147\/CMAR.S353142","volume":"14","author":"X Zhou","year":"2022","unstructured":"Zhou X, et al. Optical coherence tomography benefits the diagnosis and follow-up of primary central nervous system lymphoma with intraocular involvement. Cancer Manag Res. 2022;14:1007\u201318.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"3513_CR9","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00417-016-3395-x","volume":"254","author":"T Saito","year":"2016","unstructured":"Saito T, et al. Optical coherence tomography manifestations of primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol. 2016;254(12):2319\u201326.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3513_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/IAE.0000000000002819","volume":"41","author":"X Yang","year":"2021","unstructured":"Yang X, et al. Spectral domain optical coherence tomography features of vitreoretinal lymphoma in 55 eyes. Retina. 2021;41(2):249\u201358.","journal-title":"Retina"},{"issue":"2","key":"3513_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaophthalmol.2018.5835","volume":"137","author":"GG De\u00e1k","year":"2019","unstructured":"De\u00e1k GG, et al. Vertical hyperreflective lesions on optical coherence tomography in vitreoretinal lymphoma. JAMA Ophthalmol. 2019;137(2):194\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3513_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/ceo.14197","volume":"51","author":"W Guan","year":"2023","unstructured":"Guan W, et al. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma. Clin Exp Ophthalmol. 2023;51(2):144\u201353.","journal-title":"Clin Exp Ophthalmol"},{"issue":"17","key":"3513_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1212\/01.wnl.0000327672.04729.8c","volume":"71","author":"SA Grimm","year":"2008","unstructured":"Grimm SA, et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology. 2008;71(17):1355\u201360.","journal-title":"Neurology"},{"issue":"5","key":"3513_CR14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ajo.2008.12.025","volume":"147","author":"C Fardeau","year":"2009","unstructured":"Fardeau C, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(5):886\u201394, 894.e1.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"3513_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1136\/bjophthalmol-2017-311612","volume":"102","author":"RJ Barry","year":"2018","unstructured":"Barry RJ, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis. Br J Ophthalmol. 2018;102(10):1362\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"3513_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/09273948.2019.1648835","volume":"29","author":"A Marchese","year":"2021","unstructured":"Marchese A, et al. Features of Retinitis-like Lesions in vitreoretinal lymphoma. Ocul Immunol Inflamm. 2021;29(3):440\u20137.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"3513_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/ICB.0000000000000156","volume":"10","author":"E Papavasileiou","year":"2016","unstructured":"Papavasileiou E, Miller JB, Sobrin L. Swept-source optical coherence tomography findings in convalescent phase of treated sarcoid choroidal granulomas. Retin Cases Brief Rep. 2016;10(1):32\u20136.","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"3513_CR18","first-page":"293","volume":"24","author":"NR Goldberg","year":"2016","unstructured":"Goldberg NR, Jabs DA, Busingye J. Optical coherence tomography imaging of presumed sarcoid retinal and optic nerve nodules. Ocul Immunol Inflamm. 2016;24(3):293\u20136.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"3513_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12348-018-0154-7","volume":"8","author":"F Rasquin","year":"2018","unstructured":"Rasquin F, Kisma N, Van Bol L. Necrotising retinopathy-like lesions as a manifestation of ocular sarcoidosis. J Ophthalmic Inflamm Infect. 2018;8(1):11.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"12","key":"3513_CR20","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.ophtha.2014.06.015","volume":"121","author":"BP Nicholson","year":"2014","unstructured":"Nicholson BP, et al. Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. Ophthalmology. 2014;121(12):2393\u20138.","journal-title":"Ophthalmology"},{"issue":"2","key":"3513_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00005-015-0361-y","volume":"64","author":"J Prze\u017adziecka-Do\u0142yk","year":"2016","unstructured":"Prze\u017adziecka-Do\u0142yk J, et al. Immunopathogenic background of pars planitis. Arch Immunol Ther Exp (Warsz). 2016;64(2):127\u201337.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"3513_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/archophthalmol.2008.564","volume":"127","author":"F Forooghian","year":"2009","unstructured":"Forooghian F, et al. Uveitic foveal atrophy: clinical features and associations. Arch Ophthalmol. 2009;127(2):179\u201386.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3513_CR23","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1097\/IAE.0b013e31825f3851","volume":"32","author":"CM Eandi","year":"2012","unstructured":"Eandi CM, et al. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina. 2012;32(9):1915\u201341.","journal-title":"Retina"},{"key":"3513_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ajo.2021.03.048","volume":"228","author":"Classification Criteria for Sympathetic Ophthalmia","year":"2021","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Sympathetic Ophthalmia. Am J Ophthalmol. 2021;228:212\u201319.\u00a0","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3513_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12886-019-1045-x","volume":"19","author":"J Li","year":"2019","unstructured":"Li J, et al. Imageology features of different types of multifocal choroiditis. BMC Ophthalmol. 2019;19(1):39.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"3513_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcjo.2013.10.005","volume":"49","author":"K Pakzad-Vaezi","year":"2014","unstructured":"Pakzad-Vaezi K, et al. Optical coherence tomography in the diagnosis and management of uveitis. Can J Ophthalmol. 2014;49(1):18\u201329.","journal-title":"Can J Ophthalmol"},{"issue":"11","key":"3513_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00417-004-0973-0","volume":"242","author":"SE Coupland","year":"2004","unstructured":"Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004;242(11):901\u201313.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"3513_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/IAE.0b013e31820a6743","volume":"31","author":"R Rajagopal","year":"2011","unstructured":"Rajagopal R, Harbour JW. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina. 2011;31(3):435\u201340.","journal-title":"Retina"},{"key":"3513_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajo.2021.11.023","volume":"238","author":"F Pichi","year":"2022","unstructured":"Pichi F, et al. Advanced OCT analysis of biopsy-proven Vitreoretinal Lymphoma. Am J Ophthalmol. 2022;238:16\u201326.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3513_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ajo.2007.12.032","volume":"145","author":"JE Thorne","year":"2008","unstructured":"Thorne JE, et al. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol. 2008;145(5):841\u20136.","journal-title":"Am J Ophthalmol"},{"key":"3513_CR31","doi-asserted-by":"crossref","unstructured":"Allegri P, et al. Sarcoid Uveitis: an intriguing challenger. Medicina (Kaunas). 2022;58(7):898.","DOI":"10.3390\/medicina58070898"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03513-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T08:04:45Z","timestamp":1718265885000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3513"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03513-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects and\/or their legal guardian(s). This study was performed in accordance with the guidelines of the Declaration of Helsinki and was granted approval by the institutional review board of Mayo Clinic and informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}